article thumbnail

Europe names hundreds of critical medicines in quest to counter drug shortages

Fierce Pharma

Over the past several years, drug shortages have vexed doctors and patients on both sides of the Atlantic, prompting lawmakers and government agencies to take action in both Europe and the U.S. Tuesday, the European Medicines Agency laid out a list of more than 300 critical generic drugs that could fall prey to future shortages.

Medicine 360
article thumbnail

Should doctors refuse to treat obese patients?

World of DTC Marketing

IN BRIEF: Doctors are not required to treat obese patients who won’t do anything to lose weight but the problem is more than reminding patients they need to get exercise and drop pounds. Susan knew she needed to lose weight, especially when her doctor told her that her A1C indicated that she was prediabetic.

Doctors 250
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Even on social media “listen to the doctor”

World of DTC Marketing

He is Chair of UCSF Department of Medicine and has been actively sharing his thoughts on the latest COVID information. The post Even on social media “listen to the doctor” appeared first on World of DTC Marketing.com. Take, for example, Dr. Bob Wachter.

Media 253
article thumbnail

Is digital the future of medicine?

World of DTC Marketing

Some 70% of American hospitals still fax and post patient records, and patients don’t have one record to share among all their doctors. Digital medicine has been thrust into the spotlight because of the pandemic and the media hype is in overdrive. ” Digital medicine also needs better clarification.

Medicine 201
article thumbnail

Eli Lilly inks deal to acquire Nexus manufacturing plant in WI as Mounjaro and Zepbound shortages drag on

Fierce Pharma

As doctors and patients in the U.S. | As doctors and patients in the U.S. grapple with widening shortages of the popular diabetes therapy Mounjaro and its obesity counterpart Zepbound, the maker of the tirzepatide drugs, Eli Lilly, is forging ahead on its quest to expand capacity for its injectable medicines.

Doctors 264
article thumbnail

As cancer drug shortages persist, ASCO official urges congressional action at hearing

Fierce Pharma

A year into a dire shortage of essential cancer medicines in the U.S., The oncology drug supply crisis has entered its second year, and doctors still face "impossible choices" without access to standard-of-care therapies, ASCO's chief medical officer, Dr.

Doctors 314
article thumbnail

Roche scores FDA nod for prefilled syringe version of Vabysmo, easing its administration

Fierce Pharma

Roche has taken another step in its advancement of the blockbuster medicine, scoring an FDA nod to provide it in a prefilled syringe. The 6-mg, single-dose shot will give doctors a simplified, ready-to-use alternative to extracting Vabysmo from a vial.

FDA 298